Nasal Spray
Showing 1 - 25 of 4,350
COVID-19 Trial in Beijing (HH-120 nasal spray, PartA cohort 1, HH-120 nasal spray, Part A cohort 2-7, HH-120 nasal spray, Part A
Active, not recruiting
- COVID-19
- HH-120 nasal spray, PartA cohort 1
- +4 more
-
Beijing, Beijing, ChinaBeijing TongRen Hospital, Capital Medical University
Feb 23, 2023
COVID-19 Trial in Beijing (SA55 nasal spray)
Recruiting
- COVID-19
- SA55 nasal spray
-
Beijing, Chaoyang, ChinaBeijing Ditan Hospital Capital Medical University
Sep 15, 2023
Idiopathic Pulmonary Fibrosis Trial in Hialeah Gardens (20mM sodium pyruvate nasal spray, Saline Placebo control nasal spray)
Recruiting
- Idiopathic Pulmonary Fibrosis
- 20mM sodium pyruvate nasal spray
- Saline Placebo control nasal spray
-
Hialeah Gardens, FloridaFamily First Medical Research Center
Sep 16, 2023
Acute Rhinosinusitis Trial in Faisalabad (Mometasone Nasal 50 Mcg/Inh Nasal Spray, Nasal spray)
Completed
- Acute Rhinosinusitis
- Mometasone Nasal 50 Mcg/Inh Nasal Spray
- Nasal spray
-
Faisalabad, Punjab, PakistanSaffron Pharmaceutical
Nov 27, 2022
Allergic Rhinitis Trial in Cheras (Elonide Nasal Spray, Nasonex Nasal Spray, Normal saline)
Completed
- Allergic Rhinitis
- Elonide Nasal Spray
- +2 more
-
Cheras, Kuala Lumpur, MalaysiaDepartment of Otorhinolaryngology, Head and Neck Surgery, Facult
Jun 12, 2023
Respiratory Viral Infection Trial (Nasal Spray)
Not yet recruiting
- Respiratory Viral Infection
- Nasal Spray
- (no location specified)
Nov 19, 2022
Seasonal Allergic Rhinitis Trial in Mississauga (Treatment A: Azelastine HCl 0.15% nasal spray (Azelair), Treatment B: Placebo
Recruiting
- Seasonal Allergic Rhinitis
- Treatment A: Azelastine hydrochloride 0.15% nasal spray (Azelair)
- +2 more
-
Mississauga, Ontario, CanadaCliantha Research
Nov 6, 2023
Allergic Rhinitis Trial in Taichung, Tainan, Taipei (azelastine/fluticasone 137/50 mcg nasal spray, Dymista™)
Completed
- Allergic Rhinitis
- azelastine/fluticasone 137/50 mcg nasal spray
- Dymista™
-
Taichung, Taiwan
- +4 more
Sep 20, 2023
SARS-CoV-2, Prevention Trial in Chongqing (MY-586 SARS-CoV-2 Neutralizing Antibody nasal spray, Placebo Comparator: MY-586
Recruiting
- SARS-CoV-2
- Prevention
- MY-586 SARS-CoV-2 Neutralizing Antibody nasal spray
- Placebo Comparator: MY-586 SARS-CoV-2 Neutralization Antibody nasal excipient
-
Chongqing, Chongqing, ChinaThe Second Affiliated Hospital of Chongqing Medical University
Aug 2, 2023
SARS-CoV-2, Prevention Trial in Chongqing (A8G6 SARS-CoV-2 Neutralization Antibody combination nasal spray, A8G6 SARS-CoV-2
Recruiting
- SARS-CoV-2
- Prevention
- A8G6 SARS-CoV-2 Neutralization Antibody combination nasal spray
- A8G6 SARS-CoV-2 Neutralization Antibody nasal excipient
-
Chongqing, Chongqing, ChinaThe Second Affiliated Hospital of Chongqing Medical University
Nov 9, 2023
Preoperative Sedation of Children Trial in Beijing (Dexmedetomidine Hydrochloride Nasal Spray, Dexmedetomidine HCl nasal spray
Completed
- Preoperative Sedation of Children
- Dexmedetomidine Hydrochloride Nasal Spray
- Dexmedetomidine hydrochloride nasal spray blank preparation
-
Beijing, Beijing, ChinaBeijing Children's Hospital Affiliated to Capital Medical Univer
Nov 4, 2022
COVID-19 Trial in Beijing, Shanghai (HH-120 Nasal Spray, Placebo)
Not yet recruiting
- COVID-19
- HH-120 Nasal Spray
- Placebo
-
Beijing, China
- +1 more
Mar 27, 2023
COVID-19, SARS-CoV-2 Infection Trial in Beijing (HH-120 Nasal Spray)
Completed
- COVID-19
- SARS-CoV-2 Infection
- HH-120 Nasal Spray
-
Beijing, Beijing, ChinaBeijing Ditan Hospital,Capital Medical University
Feb 26, 2023
SARS-CoV-2 Infection Trial in Beijing (HH-120 nasal spray 1, HH-120 nasal spray 2, Placebo Comparator 1)
Completed
- SARS-CoV-2 Infection
- HH-120 nasal spray 1
- +3 more
-
Beijing, Beijing, ChinaBeijing Ditan Hospital,Capital Medical University
Mar 1, 2023
Sjogren's Syndrome, Dry Eye Trial (Varenicline Nasal Spray)
Not yet recruiting
- Sjogren's Syndrome
- Dry Eye
- Varenicline Nasal Spray
- (no location specified)
Jan 26, 2023
COVID-19 Trial in Hohhot (SA58 Nasal Spray)
Active, not recruiting
- COVID-19
- SA58 Nasal Spray
-
Hohhot, The Inner Mongolia Autonomous Region, ChinaInner Mongolia Fourth Hospital
Jan 11, 2023
Coronavirus Disease 2019(COVID-19) Trial in Beijing (HH-120 Nasal Spray)
Recruiting
- Coronavirus Disease 2019(COVID-19)
- HH-120 Nasal Spray
-
Beijing, ChinaBeijing Ditan Hospital, Capital Medical University
Dec 20, 2022
COVID-19 Trial in Beijing (SA58 Nasal Spray, Placebo)
Active, not recruiting
- COVID-19
- SA58 Nasal Spray
- Placebo
-
Beijing, ChinaBeijing Ditan Hospital, Capital Medical University
Jan 11, 2023
Dry Eye Disease Trial in Venice (Varenicline solution, Placebo nasal spray (OC-01 Vehicle Nasal Spray))
Recruiting
- Dry Eye Disease
- Varenicline solution
- Placebo nasal spray (OC-01 Vehicle Nasal Spray)
-
Venice, FloridaStephenson Eye Associates
Aug 23, 2022
Dry Eye Disease Trial in Shanghai (Varenicline Tartrate Nasal Spray)
Recruiting
- Dry Eye Disease
- Varenicline Tartrate Nasal Spray
-
Shanghai, ChinaHuashan Hospital
Dec 14, 2022
Seasonal Allergic Rhinitis Trial (Azelastine + Mometazone, nasal spray, Momat Rhino Advance)
Not yet recruiting
- Seasonal Allergic Rhinitis
- Azelastine + Mometazone, nasal spray
- Momat Rhino Advance
- (no location specified)
Dec 16, 2022
COVID-19 Trial in Chicago (Experimental: Primary Cohort, Placebo Comparator: Primary Cohort - Placebo)
Active, not recruiting
- COVID-19
- Experimental: Primary Cohort
- Placebo Comparator: Primary Cohort - Placebo
-
Chicago, IllinoisUniversity of Chicago
Aug 24, 2023
Allergic Rhinitis Trial in Wuhan (Fluticasone Nasal 50 Mcg/Inh Nasal Spray, Azelastine Nasal 140 Mcg/Inh Nasal Spray,
Not yet recruiting
- Allergic Rhinitis
- Fluticasone Nasal 50 Mcg/Inh Nasal Spray, Azelastine Nasal 140 Mcg/Inh Nasal Spray
- Fluticasone Nasal 50 Mcg/Inh Nasal Spray
-
Wuhan, Hubei, ChinaTongji Hosptial affiliated to Tongji Medical college of Huazhong
Dec 4, 2022
SARS-CoV-2 Infection Trial in Aix-en-Provence (nasal spray)
Terminated
- SARS-CoV-2 Infection
- nasal spray
-
Aix-en-Provence, FranceDr Bouvier's Office
Nov 14, 2022
Chronic Rhinitis Trial in Evanston (Azelastine (137 mcg/spray) Nasal Spray and Mometasone (50 mcg/spray) Nasal Spray, Mometasone
Not yet recruiting
- Chronic Rhinitis
- Azelastine (137 mcg/spray) Nasal Spray and Mometasone (50 mcg/spray) Nasal Spray
- +2 more
-
Evanston, IllinoisNorthshore University HealthSystem
Nov 30, 2022